Efficacy, Pharmacokinetics and Safety of Testosterone
Status:
Completed
Trial end date:
2011-07-01
Target enrollment:
Participant gender:
Summary
This is an open-label study of a single and repeated application of three dose levels of
topical testosterone in hypogonadal males with morning serum testosterone concentrations <
297 ng/dL.